Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;33(6):822-826.
doi: 10.1007/s11596-013-1205-9. Epub 2013 Dec 13.

Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy

Meng Du  1   2 , Kun Huang  1   2 , Lu Gao  2 , Liu Yang  2 , Wen-Shuo Wang  3 , Bo Wang  3 , Kai Huang  4   5 , Dan Huang  6   7
Affiliations

Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy

Meng Du et al. J Huazhong Univ Sci Technolog Med Sci. 2013 Dec.

Abstract

Pathological cardiac hypertrophy induced by angiotensin II (AngII) can subsequently give rise to heart failure, a leading cause of mortality. Nardosinone is a pharmacologically active compound extracted from the roots of Nardostachys chinensis, a well-known traditional Chinese medicine. In order to investigate the effects of nardosinone on AngII-induced cardiac cell hypertrophy and the related mechanisms, the myoblast cell line H9c2, derived from embryonic rat heart, was treated with nardosinone (25, 50, 100, and 200 μmol/L) or AngII (1 μmol/L). Then cell surface area and mRNA expression of classical markers of hypertrophy were detected. The related protein levels in PI3K/Akt/mTOR and MEK/ERK signaling pathways were examined by Western blotting. It was found that pretreatment with nardosinone could significantly inhibit the enlargement of cell surface area induced by AngII. The mRNA expression of ANP, BNP and β-MHC was obviously elevated in AngII-treated H9c2 cells, which could be effectively blocked by nardosinone at the concentration of 100 μmol/L. Further study revealed that the protective effects of nardosinone might be mediated by repressing the phosphorylation of related proteins in PI3K/Akt and MEK/ERK signaling pathways. It was suggested that the inhibitory effect of nardosinone on Ang II-induced hypertrophy in H9c2 cells might be mediated by targeting PI3K/Akt and MEK/ERK signaling pathways.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Trends Endocrinol Metab. 2004 Nov;15(9):405-8 - PubMed
    1. EMBO J. 2000 Dec 1;19(23):6341-50 - PubMed
    1. J Cell Physiol. 2011 Mar;226(3):666-74 - PubMed
    1. Mol Cell Biol. 2005 Feb;25(3):865-78 - PubMed
    1. Tetrahedron Lett. 1965 Sep;(35):3083-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources